Nephrocare Health Services (NSE: NEPHROPLUS)

Clinics/Outpatient Services · Hyderabad, India · Founded 2009 · Publicly Held

Nephrocare Health Services Ltd is a dialysis services provider company. Nephrocare Health Services (NSE: NEPHROPLUS) is based in Hyderabad, India and was founded in 2009. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $515 million (Dec 2025). It has raised $267 million across 1 recorded round; the latest was a $103 million Series F in May 2024.

Last price · $/share
—
Implied valuation
$514.5M
Total raised
$267.3M
Last round
Later Stage VC (Series F)
May 2024
What is Nephrocare Health Services (NSE: NEPHROPLUS) worth?
$514.5Mlast known valuation

Nephrocare Health Services (NSE: NEPHROPLUS) last raised $102.5M in its Later Stage VC (Series F) (May 2024).

Free account
More of Nephrocare Health Services (NSE: NEPHROPLUS) with a free account
  • ·Watch Nephrocare Health Services (NSE: NEPHROPLUS): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Nephrocare Health Services (NSE: NEPHROPLUS) funding history

1 rounds
DateRoundRaisedPost-money
May 2024Later Stage VC (Series F)$102.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Nephrocare Health Services (NSE: NEPHROPLUS) valuation

Nephrocare Health Services (NSE: NEPHROPLUS) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $515 million (Dec 2025). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.

How much has Nephrocare Health Services (NSE: NEPHROPLUS) raised?

Nephrocare Health Services (NSE: NEPHROPLUS) has raised $267 million in total; 1 of its rounds is on record. The largest on record was a $103 million Series F in May 2024.

Comparable companies

Comparable clinics/outpatient services names by valuation on PrivateMarketView: Headway (Clinics/Outpatient Services) ($2.3 billion), Galileo (Clinics/Outpatient Services) ($362 million) and Oshi Health ($200 million).

How Nephrocare Health Services (NSE: NEPHROPLUS)'s valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Nephrocare Health Services (NSE: NEPHROPLUS), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Nephrocare Health Services (NSE: NEPHROPLUS)

What is Nephrocare Health Services (NSE: NEPHROPLUS) worth?
Nephrocare Health Services (NSE: NEPHROPLUS)'s last known valuation is $514.5M.
How much has Nephrocare Health Services (NSE: NEPHROPLUS) raised?
Nephrocare Health Services (NSE: NEPHROPLUS) has raised $267.3M in total funding across 1 recorded rounds.
When did Nephrocare Health Services (NSE: NEPHROPLUS) last raise?
Nephrocare Health Services (NSE: NEPHROPLUS) last raised in May 2024 (Later Stage VC (Series F)), raising $102.5M.